A Novel Method to Evaluate Insulin Sensitivity by Combining Continuous Glucose Monitoring and Urinary C‐Peptide Excretion

Documenti analoghi

• Glucagon‐like peptide ‐1 receptor agonist ‐based agents and weight loss composition: Filling the gaps
  di: Robert L. Dubin, et al.
  Pubblicazione: (2024)
• Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES )
  di: John Armato, et al.
  Pubblicazione: (2026)
• Glycaemic Metrics Improve Significantly Within 7 Days of Continuous Glucose Monitoring Initiation in Non‐Insulin–Using People With Type 2 Diabetes
  di: Holly J. Willis, et al.
  Pubblicazione: (2026)
• Unimolecular GLP ‐1/Apelin Hybrid Peptides Cause Prominent Appetite Suppression, as Well as Enhancing Insulin Secretion, Beta‐Cell Survival and Glycaemic Regulation
  di: Ananyaa Sridhar, et al.
  Pubblicazione: (2026)
• Advances in Electrocardiogram‐Based Non‐Invasive Blood Glucose Monitoring Technology
  di: Qi Zeng, et al.
  Pubblicazione: (2026)